Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amplifon Interim / Quarterly Report 2016

Apr 27, 2016

4030_10-q_2016-04-27_00b1af33-6b6b-4899-97e6-747b81ef17dc.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Informazione
Regolamentata n.
0525-60-2016
Data/Ora Ricezione
27 Aprile 2016 11:17:09
MTA - Star
Societa' : AMPLIFON
Identificativo
Informazione
Regolamentata
: 73128
Nome utilizzatore : AMPLIFONNSS01 - Giorcelli
Tipologia : IROS 08; IRAG 03
Data/Ora Ricezione : 27 Aprile 2016 11:17:09
Data/Ora Inizio
Diffusione presunta
: 27 Aprile 2016 11:32:10
Oggetto : FIRST QUARTER OF 2016 AMPLIFON: STRONG RESULTS IN THE
Testo del comunicato

Vedi allegato.

AMPLIFON: STRONG RESULTS IN THE FIRST QUARTER OF 2016

REVENUES RISE 11.2% AT CONSTANT EXCHANGE RATES, DRIVEN BY SOLID ORGANIC GROWTH BALANCED ACROSS ALL THE REGIONS WHERE THE COMPANY OPERATES. SIGNIFICANT IMPROVEMENT IN ALL PROFITABILITY INDICATORS. NETWORK EXPANSION PROGRAM CONTINUES WITH 48 NEW STORES AND SHOP-IN-SHOPS

  • Consolidated REVENUES were Euro 254.5 million, up 11.2% at constant exchange rates and 10.0% at current exchange rates compared to the first quarter of 2015
  • EBITDA amounted to Euro 34.0 million, or 13.4% of revenues (13.1% in the first quarter of 2015), an increase of 12.1% compared to the same period of the prior year
  • NET PROFIT amounted to Euro 8.6 million, an increase of 142.8% compared to the first quarter of 2015. Net of the non-recurring expenses incurred last year, the increase was 39.4%
  • NET FINANCIAL DEBT was Euro 213.1 million, a significant improvement over Euro 260.9 million reported at March 31st , 2015 and slightly higher – due to seasonality – compared to the Euro 204.9 million posted at December 31st , 2015
  • FREE CASH FLOW generation was essentially neutral, in line with period seasonality
(Euro millions) First Quarter 2016
First quarter* % on revenues Result before
non recurring
operations
% on revenues
before non
recurring
operations
Non recurring
operations
First quarter
after the
impact of non
recurring
operations
Change on
values before
non recurring
operations
%
Net revenues 254.5 100.0% 231.3 100.0% - 231.3 10.0%
EBITDA 34.0 13.4% 30.3 13.1% - 30.3 12.1%
EBIT 21.4 8.4% 17.7 7.6% - 17.7 20.8%
Net income 8.6 3.4% 6.2 2.7% (2.7) 3.5 39.4%
Free cash flow (0.3) (4.0)
(Euro millions) 31/03/2016 31/12/2015 Change %
Net financial position 213.1 204.9 4.0%

MAIN ECONOMICAL AND FINANCIAL FIGURES – I QUARTER 2016

* There have been no non recurring operations in the reference period

Milan, April 27th , 2016 - The Board of Directors of Amplifon S.p.A., global leader in hearing solutions and services, approved today, in a meeting chaired by Susan Carol Holland, the Interim Management Report as at March 31st, 2016.

"We started the year with an excellent quarter, notwithstanding the negative exchange effect and a challenging comparison with the same period of the prior year. Revenue growth was driven by a significant acceleration in organic growth and the continued expansion of our network. Strong performances were posted in all the markets where the Company operates, particularly in Europe, thus further strengthening our global leadership position", said Enrico Vita, Amplifon's Chief Executive Officer. "The new approach to communication and marketing, the high level of service and the network expansion in core markets demonstrate the validity of our strategic choices. The results achieved allow us to confirm the expectations for growth in the next quarters and in the years to come".

OVERVIEW

Amplifon reported consolidated revenues of Euro 254.5 million in the first quarter of 2016, an increase of 11.2% at constant exchange rates and of 10.0% at current exchange rates compared to the first quarter of 2015. This result reflects strong organic growth (+8.1%), acquisitions (+3.1%) and the negative foreign exchange effect of 1.2%. This overall result was achieved thanks to the strong performances recorded in all geographies where the Company is present, with a particularly outstanding performance reported in EMEA. EBITDA amounted to Euro 34.0 million, an improvement in both relative terms (+12.1%) and as a percentage of sales (+30 basis points), after the increased marketing investments incurred in the period to accelerate future growth and despite the comparison with the same period of the prior year which benefitted from the Euro 0.6 million capital gain generated by the sale of the Biomedica business in Italy. Net profit for the period was Euro 8.6 million, up 142.8% compared to the first quarter of 2015. Net of the non-recurring expenses incurred in the first quarter of 2015, the increase was 39.4%.

The balance sheet and cash flow indicators performed well in the period: free cash flow was essentially neutral, in line with period seasonality, while the net financial debt of Euro 213.1 million, improved significantly compared to the Euro 260.9 million posted at March 31st , 2015 and was up slightly – again due to seasonality – compared to the Euro 204.9 million reported at December 31st , 2015.

The expansion program continued in the quarter, both organically and through acquisitions, adding 24 stores and 24 shop-in-shops. The new openings, 7 stores and 24 shop-in-shops, were mainly located in the Iberian Peninsula and Australia; while the acquisitions of 17 stores were made primarily in France and Germany.

FINANCIAL RESULTS FOR FIRST QUARTER OF 2016

Consolidated revenues reached Euro 254.5 million in the first quarter of 2016, an increase – thanks to the contribution from all Regions – of 10.0% compared to the same period 2015. Revenues were driven by solid organic growth (+8.1%) and acquisitions (3.1%). The foreign exchange effect, instead, had a negative impact of 1.2%.

Thanks to the significant growth in revenues, EBITDA rose 12.1% to Euro 34.0 million, with the EBITDA margin coming in at 13.4% compared to 13.1% in the first quarter of 2015. This result was achieved after the increased marketing investments incurred in the period to accelerate future growth and despite the comparison with the same period of the prior year which benefitted from the Euro 0.6 million capital gain generated by the sale of the Biomedica business in Italy. Net of this gain, the EBITDA margin rose by more than 50 basis points. All regions contributed to the overall improvement in profitability. The EBITDA margin for EMEA improved markedly, rising from the 10.5% recorded in the first quarter of 2015 to 12.2% in the first quarter of 2016, an increase of 30.6% in absolute terms. EBITDA in the AMERICAS reached Euro 9.5 million, an increase of 5.7% compared to the same period of the prior year, with the EBITDA margin contracting 40 basis points as a result of the increased investments made in the period to accelerate future growth. ASIA-PACIFIC closed the quarter with EBITDA of Euro 9.3 million, down slightly (-3.4%) compared to the prior year due primarily to the negative foreign exchange effect. In local currency, EBITDA was in fact up 3.9% compared to the same period of the prior year.

EBIT amounted to Euro 21.4 million (+20.8%), or 8.4% of revenues, an increase of 80 basis points compared to the same period of the prior year. Net profit (NP) reached Euro 8.6 million, an increase of 142.8% compared to the first quarter of 2015, which was impacted by the make whole payment made following advance repayment of the Private Placement 2006-2016. Net of these non-recurring costs, the increase was 39.4%.

PERFORMANCE BY GEOGRAPHIC AREA

EMEA: solid organic growth and improved profitability

Revenues in Europe, the Middle East and Africa (EMEA) reached Euro 169.9 million, an increase of 12.1% compared to the same period of the prior year. This result was driven for 9.0% by strong organic growth and for 3.6% by acquisitions, while the foreign exchange effect had a negative impact of 0.5%. A stellar performance was posted in Italy, where growth reached 15.1% compared the first quarter of 2015: this result, mainly due to organic growth, reflects the positive impact of the new marketing initiatives, including the campaign launched in 2015. Revenues rose 8.5% in France - 7.4% due to acquisitions – despite the comparison with a particularly strong first quarter 2015. A good performance was reported in the Netherlands where, thanks to increased volumes and despite a reference market subject to significant price pressure, sales rose 7.7%, driven entirely by organic growth. Germany reported an increase of 28.7%, attributable to acquisitions (22.3%), but also boosted by noticeable organic growth (+6.4%). The Iberian Peninsula also performed well, posting a 15.9% increase in sales thanks to both organic growth and the opening of new stores. In Switzerland revenue growth reached 8.1% in local currency, despite the difficult comparison with the same period of the prior year. Sales in Belgium and Luxembourg (BeLux) rose 12.3% thanks to solid organic growth. In the United Kingdom the increase in sales was in line with expectations (+0.6% in local currency). Lastly, Hungary, Poland and other countries of the Middle East and Africa (MEA) increased their contribution to EMEA's total revenues. The Region's profitability improved, with EBITDA reaching Euro 20.7 million and the EBITDA margin rising 170 basis points to 12.2%. Net of the capital gain generated by the sale of the Biomedica business in Italy in the first quarter of 2015, the EBITDA margin was up by more than 210 basis points.

AMERICAS: solid performance, driven by Miracle Ear

Revenues in the AMERICAS reached Euro 50.0 million in the first quarter of 2016, up 7.9% compared to the same period of the prior year at current exchange rates and 6.2% in local currency. This result is explained for 4.8% by sustained organic growth and for 1.4% by acquisitions. All businesses in North America recorded positive performances. Miracle-Ear kicked the year off with strong growth, thanks to the positive impact of the marketing initiatives launched in 2015 and the opening of 14 franchises; Elite Hearing Network reported a positive performance despite the termination of a contract with a commercial partner in the third quarter of 2015; lastly, Amplifon Hearing Health Care benefited in particular from a contract signed with a premiere insurance company in the fourth quarter of 2014. EBITDA rose 5.7% to Euro 9.5 million, showing a slight margin contraction of 40 basis points mainly due to the increased investments made to accelerate future growth.

ASIA-PACIFIC: sustained growth, impacted by adverse currency movements

Revenues in ASIA-PACIFIC amounted to Euro 34.4 million in the first quarter of 2016, an increase of 11.1% at constant exchange rates compared to the same period of the prior year. This performance was driven for 8.4% by solid organic growth and for 2.7% by acquisitions. The foreign exchange effect had a negative impact of 8.2%. A particularly brilliant result was posted in Australia, where overall growth reached 13.4% in local currency, driven by an outstanding increase in productivity of its distribution channel and further expansion of the network. Despite the very challenging comparison with the prior year – due to a simplified regulatory environment – sales in New Zealand rose 3.0% in local currency, thanks also to the consolidation of the Dilworth Hearing Limited acquisition. The region's EBITDA fell slightly to Euro 9.3 million, due to negative foreign exchange effect; in local currency EBITDA was, in fact, 3.9% higher than the same period in 2015.

BALANCE SHEET FIGURES AS AT MARCH 31ST , 2016

All balance sheet indicators remained positive, confirming the Company's solid financial structure and ability to sustain its ambitious growth strategy. Net equity amounted to Euro 503.4 million at March 31st, 2016, an increase compared to the Euro 500.2 million posted at the end of December 2015. Net financial debt amounted to Euro 213.1 million, decidedly better than the Euro 260.9 million posted at March 31st, 2015 and slightly higher – due to seasonality – compared to the Euro 204.9 million posted at December 31st, 2015 despite the Euro 5.5 million cash-out for acquisitions made during the quarter. Net debt/EBITDA ratio was 1.26x at March 31st, 2016. Lastly, the Company's free cash flow was negative for Euro 0.3 million in the first quarter of 2016 (after absorbing capex, after disposals, of Euro 7.7 million), compared to negative free cash flow of Euro 4.0 million in the first quarter of 2015 - in line with period seasonality.

OUTLOOK

For the rest of 2016 the Company expects the positive trend in sales and profitability to continue thanks to solid organic growth which will benefit from the new marketing campaigns (including the launch of a new brand identity toward the middle of the year) and the offer of innovative services to further strengthen consumer engagement, as well as the continuous expansion of the network. As already announced in March, during the Analyst & Investor Day, the Company will focus on consolidating its leadership in key core countries (the United States, Italy and Australia) and on strengthening its competitive positioning in selected markets with high growth potential (France, Germany and Spain).

With regard to the different geographies, the Company expects solid sales growth and profitability improvement in Europe thanks to the continued store network expansion, both via acquisitions (France, Germany) and new openings (the Iberian Peninsula), and thanks to the benefits derived from marketing and communication investments. Revenues is expected to continue to grow at a robust rate in the Americas thanks to the contribution of all the Region's businesses which will benefit from new marketing initiatives and commercial policies fostered by increased investments. Lastly, in Asia–Pacific the Company expects stable organic growth above market performance, and will continue to focus on operating efficiency in order to maintain its current profitability levels.

ASSIGNMENT OF THE BENEFICIARIES OF THE NEW PERFORMANCE STOCK GRANT PLAN

Today the Board of Directors approved amendments to the Regulations for the New Performance Stock Grant Plan 2014-2021 in execution of the resolution approved by shareholders during the Shareholders' Meeting held on April 18th, 2016 which call for a few changes to be made to the plan relative solely to French beneficiaries and an updated list of the potential beneficiaries who are members of the Issuer's Board of Directors or directors of the Issuer's subsidiaries. Lastly, the Board of Directors resolved to assign, based on the Remuneration and Appointments Committee's recommendations and pursuant to Art. 84 bis, par. 5 of Consob Regulation n. 11971/99, as amended, the third award cycle of the performance stock grant plan (for the period 2016-2018) which calls for the assignment of 2,090,000 shares with allocation date of April 27th , 2016.

The Information Document relating to the new Performance Stock Grant Plan 2014-2021, which contains all the detailed information, including the table prepared in accordance with the indications provided in Table n. 1, Form 7 of Annex 3A of Regulation n. 11971/1999 required by current law, will be made available in accordance with the law at the corporate headquarters and published on the company's website www.amplifon.com/corporate.

*****

The results for the first quarter of 2016 will be presented to the financial community today at 15:00 (CET) during a conference call. To participate in the conference call dial one of the following numbers: +44 (0)207 1620 177 (UK), +1 334 323 6203 (USA) or +39 02 303 509 005 (Italy) - Conference ID: 958412. Prior to the beginning of the conference call, from 14:00 (CET), the slides to be used during the presentation will be made available on the website www.amplifon.com/corporate in the Investors section (Presentations). For those who are unable to participate, a recording of the call will be available through 24:00 (CET) on April 29th, 2016 by dialing +44 (0)207 031 4064 (UK), +1 954 334 0342 (USA) or +39 02 303 509 364 (Italy), access code: 958412.

In compliance with paragraph 2 of Article 154 bis of the "Uniform Financial Services Act" (Legislative Decree 58/1998), the Manager charged with preparing the Company's financial reports, Ugo Giorcelli, declares that the accounting information reported in the present press release corresponds to the underlying documentary reports, books of account and accounting entries.

*****

Pursuant to IFRS 8 – "Operating Segments", based on a corresponding change in the reports periodically analyzed by the Chief Executive Officer and the Company's Top Management, the schedules relating to segment information have been revised in order to expose separately data by direct competence of leaders of the Regions and the costs of the Company's central functions (corporate bodies, general management, business development, procurement, treasury, legal affairs, human resources, IT systems, global marketing and internal audit) which do not qualify as operating segments under IFRS 8. The financial statements relative to the first quarter of 2015 have been, consequently, restated.

*****

This press release contains forward-looking statements. These statements are based on the Company's current expectations and projections about future events and, by their nature, are subject to inherent risks and uncertainties. They relate to events and depend on circumstances that may or may not occur or exist in the future, and, as such, undue reliance should not be placed on them. Actual results may differ materially from those expressed in such statements as a result of a variety of factors, including: continued volatility and further deterioration of capital and financial markets, changes in general macro-economic conditions, economic growth and other changes in business conditions, changes in laws and regulations (both in Italy and abroad), and many other factors, most of which are outside of the Company's control.

*****

About Amplifon

Amplifon, listed on the STAR segment of the Italian Stock Exchange, is the global leader in hearing solutions and services for retail expertise, customization and consumer care. Through a network of approximately 3,500 points of sale, 3,500 service centers and 1,700 affiliates, Amplifon is active in 22 countries across EMEA (Italy, France, the Netherlands, Germany, the UK, Ireland, Spain, Portugal, Switzerland, Belgium, Luxembourg, Hungary, Egypt, Turkey, Poland and Israel), Americas (U.S.A., Canada and Brazil) and APAC (Australia, New Zealand and India). With approximately 5,500 hearing care professionals, the Company is committed to delivering the highest quality of service and care, in order to achieve the best hearing experience for customers worldwide. More information about the Group available at: www.amplifon.com/corporate.

Contacts:

Investor Relations Amplifon S.p.A. Francesca Rambaudi Tel +39 02 5747 2261 Fax +39 02 5740 9427 [email protected] Media Relations: Edelman Italia Luciano Luffarelli Tel +39 02 631161 Mob +39 335 1320467 [email protected]

NET REVENUES BY GEOGRAPHIC AREA - AMPLIFON GROUP

(€ thousands) First
Quarter
2016
% First
Quarter
2015
% Change Change
%
Exchange
diff.
Change %
in local
currency
Organic
growth %
Italy 59,091 23.2% 51,318 22.2% 7,773 15.1% 15.1%
France 30,047 11.8% 27,704 12.0% 2,343 8.5% 1.1%
Germany 17,986 7.1% 13,975 6.0% 4,011 28.7% 6.4%
The Netherlands 16,454 6.5% 15,282 6.6% 1,172 7.7% 7.7%
Switzerland 10,411 4.1% 9,846 4.3% 565 5.7% (231) 8.1% 8.1%
United Kingdom 10,088 4.0% 10,391 4.5% (303) -2.9% (367) 0.6% 0.6%
Spain 8,871 3.5% 7,776 3.4% 1,095 14.1% 11.7%
Belgium 6,682 2.6% 5,972 2.6% 710 11.9% 11.1%
Israel 3,799 1.5% 3,443 1.5% 356 10.3% 119 6.9% 3.4%
Hungary 1,786 0.7% 1,741 0.8% 45 2.6% (18) 3.6% 3.6%
Portugal 1,714 0.7% 1,357 0.6% 357 26.3% 26.3%
Turkey 1,007 0.4% 1,011 0.4% (4) -0.4% (172) 16.6% 16.6%
Egypt 927 0.4% 880 0.4% 47 5.3% (44) 10.4% 10.4%
Poland 683 0.3% 522 0.2% 161 30.8% (29) 36.2% 36.2%
Ireland 211 0.1% 190 0.1% 21 11.1% 11.1%
Luxembourg 187 0.1% 139 0.1% 48 34.5% 34.5%
Intercompany elimination (45) 0.0% (41) 0.0% (4) -
Total EMEA 169,899 66.8% 151,506 65.5% 18,393 12.1% (742) 12.6% 9.0%
USA 48,017 18.9% 44,825 19.4% 3,192 7.1% 1,030 4.8% 4.4%
Canada 1,591 0.6% 1,246 0.5% 345 27.7% (136) 38.5% -0.1%
Brazil 374 0.1% 260 0.1% 114 43.8% (125) 92.2% 92.2%
Total Americas 49,982 19.6% 46,331 20.0% 3,651 7.9% 769 6.2% 4.8%
Australia 23,460 9.2% 22,097 9.6% 1,363 6.2% (1,606) 13.4% 13.4%
New Zealand 9,572 3.8% 10,318 4.5% (746) -7.2% (1,054) 3.0% -5.9%
India 1,403 0.6% 1,040 0.4% 363 34.9% (87) 43.2% 43.2%
Total Asia Pacific 34,435 13.5% 33,455 14.5% 980 2.9% (2,747) 11.1% 8.4%
Corporate and intercompany
elimination
204 0.1% 49 0.0% 155 -
Total 254,520 100.0% 231,341 100.0% 23,179 10.0% (2,720) 11.2% 8.1%

PROFIT AND LOSS - AMPLIFON GROUP

First
Quarter
First
Quarter
Change
(€ thousands) 2016 % 2015 % %
Revenues from sales and services 254,520 100.0% 231,341 100.0% 10.0%
Operating costs (219,644) -86.3% (202,288) -87.4% 8.6%
Other costs and revenues (881) -0.3% 1,262 0.5% -169.8%
Gross operating profit (EBITDA) 33,995 13.4% 30,315 13.1% 12.1%
Depreciation and write-downs of non-current assets (8,920) -3.5% (8,850) -3.8% 0.8%
Operating result before the amortisation and impairment of customer lists,
trademarks, non-competition agreements and goodwill arising from business
combinations (EBITA)
25,075 9.9% 21,465 9.3% 16.8%
Amortization and impairment of trademarks, customer lists, lease rights and non
competition agreements and goodwill
(3,708) -1.5% (3,777) -1.6% -1.8%
Operating profit (EBIT) 21,367 8.4% 17,688 7.6% 20.8%
Income, expenses, valuation and adjustments of financial assets 175 0.1% 296 0.1% -40.9%
Net financial expenses (4,747) -1.9% (9,537) -4.1% -50.2%
Exchange differences and non hedge accounting instruments (56) 0.0% (295) -0.1% -81.0%
Profit (loss) before tax 16,739 6.6% 8,152 3.5% 105.3%
Current tax (8,852) -3.5% (5,878) -2.5% 50.6%
Deferred tax 685 0.3% 1,201 0.5% -43.0%
Net profit (loss) 8,572 3.4% 3,475 1.5% 146.7%
Profit (loss) of minority interests (2) 0.0% (57) 0.0% -96.5%
Net profit (loss) attributable to the Group 8,574 3.4% 3,532 1.5% 142.8%

SEGMENT INFORMATION

(€ thousands) First Quarter 2016 First Quarter 2015
EMEA Americas Asia Pacific Corporate
(*)
Total EMEA Americas Asia Pacific Corporate
(*)
Total
Net Revenues 169,899 49,982 34,435 204 254,520 151,506 46,331 33,455 49 231,341
EBITDA by sector 20,728 9,481 9,349 (5,563) 33,995 15,868 8,970 9,677 (4,200) 30,315
% on sales 12.2% 19.0% 27.1% -2.2% 13.4% 10.5% 19.4% 28.9% -1.8% 13.1%
EBIT by sector 12,770 8,383 6,661 (6,447) 21,367 8,050 7,849 6,762 (4,973) 17,688
% on sales 7.5% 16.8% 19.3% -2.5% 8.4% 5.3% 16.9% 20.2% -2.1% 7.6%

(*) Based on a corresponding change in the reports periodically analyzed by the Chief Executive Officer and the Company's Top

Management, the schedules relating to segment information have been revised in order to expose separately data by direct competence of leaders of the Regions and the costs of the Company's central functions (previously reported in the EMEA region). Figures for the first quarter of 2015 have been, accordingly, restated.

There have been no eliminations in the reference periods.

The weight of Corporate costs is calculated on Company's revenues.

BALANCE SHEET - AMPLIFON GROUP

(€ thousands) 31/03/2016 31/12/2015 Change
Goodwill 572,701 572,150 551
Non-competition agreements, trademarks, customer lists and lease rights 96,112 98,115 (2,003)
Software, licenses, other intangible fixed assets , fixed assets in progress and advances 42,368 43,298 (930)
Tangible assets 101,406 102,675 (1,269)
Financial fixed assets (1) 38,441 42,326 (3,885)
Other non-current financial assets (1) 4,291 4,236 55
Non-current assets 855,319 862,800 (7,481)
Inventories 32,422 28,956 3,466
Trade receivables 105,524 111,727 (6,203)
Other receivables 44,612 34,068 10,544
Current assets (A) 182,558 174,751 7,807
Operating assets 1,037,877 1,037,551 326
Trade payables (104,501) (113,343) 8,842
Other payables (2) (131,215) (131,432) 217
Provisions for risks and charges (current portion) (1,378) (1,378) -
Current liabilities (B) (237,094) (246,153) 9,059
Net working capital (A) - (B) (54,536) (71,402) 16,866
Derivative instruments (3) (8,470) (6,988) (1,482)
Deferred tax assets 41,540 40,743 797
Deferred tax liabilities (54,748) (55,695) 947
Provisions for risks and charges (non-current portion) (45,852) (48,407) 2,555
Liabilities for employees' benefits (non-current portion) (15,827) (15,572) (255)
Loan fees (4) 2,011 2,197 (186)
Other non-current payables (2,908) (2,600) (308)
NET INVESTED CAPITAL 716,529 705,076 11,453
Group net equity 503,085 499,471 3,614
Minority interests 334 694 (360)
Total net equity 503,419 500,165 3,254
Net medium and long-term financial indebtedness (4) 382,120 382,542 (422)
Net short-term financial indebtedness (4) (169,010) (177,631) 8,621
Total net financial indebtedness 213,110 204,911 8,199
OWN FUNDS AND NET FINANCIAL INDEBTEDNESS 716,529 705,076 11,453

DEBT MATURITY PROFILE – AMPLIFON GROUP

2019 and
(€ millions) 2016 2017 2018 beyond Total
Eurobond 0,0 0,0 0,0(275.0) (275.0)
Private placement 0,0 0,0 0,0 (100.9) (100.9)
Bank overdraft (14.3) 0,0 0,0 0,0 (14.3)
Others (5.2) (6.0) (0.5) (0.2) (12.0)
Cash and cash equivalents 189.0 189.0
Total 169.5 (6.0) (275.5) (101.1) (213.1)

CASH FLOW STATEMENT - AMPLIFON GROUP

(€ thousands) First Quarter 2016 First Quarter 2015
EBIT 21,367 17,688
Amortization, depreciation and write down 12,627 12,627
Provisions, other non-monetary items and gain/losses from disposals 5,528 3,647
Net financial expenses (4,387) (9,481)
Taxes paid (5,123) (7,903)
Changes in net working capital (22,681) (12,920)
Cash flow provided by (used in) operating activities 7,331 3,658
Cash flow provided by (used in) operating investing activities (7,679) (7,688)
Free Cash Flow (348) (4,030)
Cash flow provided by (used in) acquisitions (5,525) (7,344)
Cash flow provided by (used in) securities 6 99
Cash flow provided by (used in) investing activities (13,198) (14,933)
Cash flow provided by (used in) operating activities and investing activities (5,867) (11,275)
Treasury shares (2,481) (594)
Capital increases, third parties contributions and dividends paid by subsidiaries to third parties (181) 689
Hedging instruments and other changes in non current assets 367 (1,299)
Net cash flow from the period (8,162) (12,479)
Net financial indebtedness as of period opening date (204,911) (248,417)
Effect of activity disposal and exchange rate fluctuations on financial position (37) (40)
Change in net financial position (8,162) (12,479)
Net financial indebtedness as of period closing date (213,110) (260,936)